Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 24 entries
Sorted by: Best Match Show Resources per page
Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study.

Journal of the American Heart Association

Wang W, Norby FL, Zhang MJ, Reyes JL, Shah AM, Soliman EZ, Lutsey PL, Alonso A, Solomon SD, Inciardi RM, Chen LY.
PMID: 34713724
J Am Heart Assoc. 2021 Nov 02;10(21):e021723. doi: 10.1161/JAHA.121.021723. Epub 2021 Oct 29.

Background Black Americans have more atrial fibrillation risk factors but lower atrial fibrillation risk than White Americans. Left atrial (LA) enlargement and/or dysfunction, frequent atrial tachycardia (AT), and premature atrial contractions (PAC) are associated with increased atrial fibrillation risk....

Cite
Wang W, Norby FL, Zhang MJ, et al. Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study. J Am Heart Assoc. 2021;10(21):e021723doi: 10.1161/JAHA.121.021723.
Wang, W., Norby, F. L., Zhang, M. J., Reyes, J. L., Shah, A. M., Soliman, E. Z., Lutsey, P. L., Alonso, A., Solomon, S. D., Inciardi, R. M., & Chen, L. Y. (2021). Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study. Journal of the American Heart Association, 10(21), e021723. https://doi.org/10.1161/JAHA.121.021723
Wang, Wendy, et al. "Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study." Journal of the American Heart Association vol. 10,21 (2021): e021723. doi: https://doi.org/10.1161/JAHA.121.021723
Wang W, Norby FL, Zhang MJ, Reyes JL, Shah AM, Soliman EZ, Lutsey PL, Alonso A, Solomon SD, Inciardi RM, Chen LY. Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study. J Am Heart Assoc. 2021 Nov 02;10(21):e021723. doi: 10.1161/JAHA.121.021723. Epub 2021 Oct 29. PMID: 34713724; PMCID: PMC8751819.
Copy Download .nbib Format: NLM
Short-term repeatability of the peguero-lo presti electrocardiographic left ventricular hypertrophy criteria.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc

Drager D, Soliman EZ, Meyer ML, Zhang ZM, Alonso A, Heiss G, Whitsel EA.
PMID: 33591619
Ann Noninvasive Electrocardiol. 2021 May;26(3):e12829. doi: 10.1111/anec.12829. Epub 2021 Feb 16.

BACKGROUND: Electrocardiographic left ventricular hypertrophy (ECG-LVH) represents preclinical cardiovascular disease and predicts cardiovascular disease morbidity and mortality. While the newly developed Peguero-Lo Presti ECG-LVH criteria have greater sensitivity for LVH than the Cornell voltage and Sokolow-Lyon criteria, its short-term...

Cite
Drager D, Soliman EZ, Meyer ML, et al. Short-term repeatability of the peguero-lo presti electrocardiographic left ventricular hypertrophy criteria. Ann Noninvasive Electrocardiol. 2021;26(3):e12829doi: 10.1111/anec.12829.
Drager, D., Soliman, E. Z., Meyer, M. L., Zhang, Z. M., Alonso, A., Heiss, G., & Whitsel, E. A. (2021). Short-term repeatability of the peguero-lo presti electrocardiographic left ventricular hypertrophy criteria. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 26(3), e12829. https://doi.org/10.1111/anec.12829
Drager, Dominique, et al. "Short-term repeatability of the peguero-lo presti electrocardiographic left ventricular hypertrophy criteria." Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc vol. 26,3 (2021): e12829. doi: https://doi.org/10.1111/anec.12829
Drager D, Soliman EZ, Meyer ML, Zhang ZM, Alonso A, Heiss G, Whitsel EA. Short-term repeatability of the peguero-lo presti electrocardiographic left ventricular hypertrophy criteria. Ann Noninvasive Electrocardiol. 2021 May;26(3):e12829. doi: 10.1111/anec.12829. Epub 2021 Feb 16. PMID: 33591619; PMCID: PMC8164147.
Copy Download .nbib Format: NLM
Epigenetic Age and the Risk of Incident Atrial Fibrillation.

Circulation

Roberts JD, Vittinghoff E, Lu AT, Alonso A, Wang B, Sitlani CM, Mohammadi-Shemirani P, Fornage M, Kornej J, Brody JA, Arking DE, Lin H, Heckbert SR, Prokic I, Ghanbari M, Skanes AC, Bartz TM, Perez MV, Taylor KD, Lubitz SA, Ellinor PT, Lunetta KL, Pankow JS, Paré G, Sotoodehnia N, Benjamin EJ, Horvath S, Marcus GM.
PMID: 34587750
Circulation. 2021 Dec 14;144(24):1899-1911. doi: 10.1161/CIRCULATIONAHA.121.056456. Epub 2021 Sep 30.

BACKGROUND: The most prominent risk factor for atrial fibrillation (AF) is chronological age; however, underlying mechanisms are unexplained. Algorithms using epigenetic modifications to the human genome effectively predict chronological age. Chronological and epigenetic predicted ages may diverge in a...

Cite
Roberts JD, Vittinghoff E, Lu AT, et al. Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation. 2021;144(24):1899-1911doi: 10.1161/CIRCULATIONAHA.121.056456.
Roberts, J. D., Vittinghoff, E., Lu, A. T., Alonso, A., Wang, B., Sitlani, C. M., Mohammadi-Shemirani, P., Fornage, M., Kornej, J., Brody, J. A., Arking, D. E., Lin, H., Heckbert, S. R., Prokic, I., Ghanbari, M., Skanes, A. C., Bartz, T. M., Perez, M. V., Taylor, K. D., Lubitz, S. A., Ellinor, P. T., Lunetta, K. L., Pankow, J. S., Paré, G., Sotoodehnia, N., Benjamin, E. J., Horvath, S., & Marcus, G. M. (2021). Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation, 144(24), 1899-1911. https://doi.org/10.1161/CIRCULATIONAHA.121.056456
Roberts, Jason D, et al. "Epigenetic Age and the Risk of Incident Atrial Fibrillation." Circulation vol. 144,24 (2021): 1899-1911. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.056456
Roberts JD, Vittinghoff E, Lu AT, Alonso A, Wang B, Sitlani CM, Mohammadi-Shemirani P, Fornage M, Kornej J, Brody JA, Arking DE, Lin H, Heckbert SR, Prokic I, Ghanbari M, Skanes AC, Bartz TM, Perez MV, Taylor KD, Lubitz SA, Ellinor PT, Lunetta KL, Pankow JS, Paré G, Sotoodehnia N, Benjamin EJ, Horvath S, Marcus GM. Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation. 2021 Dec 14;144(24):1899-1911. doi: 10.1161/CIRCULATIONAHA.121.056456. Epub 2021 Sep 30. PMID: 34587750.
Copy Download .nbib Format: NLM
Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study.

Journal of the American Heart Association

Wang W, Norby FL, Zhang MJ, Reyes JL, Shah AM, Soliman EZ, Lutsey PL, Alonso A, Solomon SD, Inciardi RM, Chen LY.
PMID: 34713724
J Am Heart Assoc. 2021 Nov 02;10(21):e021723. doi: 10.1161/JAHA.121.021723. Epub 2021 Oct 29.

Background Black Americans have more atrial fibrillation risk factors but lower atrial fibrillation risk than White Americans. Left atrial (LA) enlargement and/or dysfunction, frequent atrial tachycardia (AT), and premature atrial contractions (PAC) are associated with increased atrial fibrillation risk....

Cite
Wang W, Norby FL, Zhang MJ, et al. Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study. J Am Heart Assoc. 2021;10(21):e021723doi: 10.1161/JAHA.121.021723.
Wang, W., Norby, F. L., Zhang, M. J., Reyes, J. L., Shah, A. M., Soliman, E. Z., Lutsey, P. L., Alonso, A., Solomon, S. D., Inciardi, R. M., & Chen, L. Y. (2021). Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study. Journal of the American Heart Association, 10(21), e021723. https://doi.org/10.1161/JAHA.121.021723
Wang, Wendy, et al. "Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study." Journal of the American Heart Association vol. 10,21 (2021): e021723. doi: https://doi.org/10.1161/JAHA.121.021723
Wang W, Norby FL, Zhang MJ, Reyes JL, Shah AM, Soliman EZ, Lutsey PL, Alonso A, Solomon SD, Inciardi RM, Chen LY. Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study. J Am Heart Assoc. 2021 Nov 02;10(21):e021723. doi: 10.1161/JAHA.121.021723. Epub 2021 Oct 29. PMID: 34713724; PMCID: PMC8751819.
Copy Download .nbib Format: NLM
Association of arterial stiffness with incident atrial fibrillation: a cohort study.

BMC cardiovascular disorders

Almuwaqqat Z, Claxton J'S, Norby FL, Lutsey PL, Wei J, Soliman EZ, Chen LY, Matsushita K, Heiss G, Alonso A.
PMID: 34016038
BMC Cardiovasc Disord. 2021 May 20;21(1):247. doi: 10.1186/s12872-021-02057-8.

BACKGROUND: Stiff arteries increase left ventricular (LV) end-systolic workload, leading over time to left atrial and ventricular remodeling, and providing the substrate for atrial fibrillation (AF) development. We investigated if carotid femoral pulse wave velocity (cfPWV), a measure of...

Cite
Almuwaqqat Z, Claxton J'S, Norby FL, et al. Association of arterial stiffness with incident atrial fibrillation: a cohort study. BMC Cardiovasc Disord. 2021;21(1):247doi: 10.1186/s12872-021-02057-8.
Almuwaqqat, Z., Claxton, J. '. S., Norby, F. L., Lutsey, P. L., Wei, J., Soliman, E. Z., Chen, L. Y., Matsushita, K., Heiss, G., & Alonso, A. (2021). Association of arterial stiffness with incident atrial fibrillation: a cohort study. BMC cardiovascular disorders, 21(1), 247. https://doi.org/10.1186/s12872-021-02057-8
Almuwaqqat, Zakaria, et al. "Association of arterial stiffness with incident atrial fibrillation: a cohort study." BMC cardiovascular disorders vol. 21,1 (2021): 247. doi: https://doi.org/10.1186/s12872-021-02057-8
Almuwaqqat Z, Claxton J'S, Norby FL, Lutsey PL, Wei J, Soliman EZ, Chen LY, Matsushita K, Heiss G, Alonso A. Association of arterial stiffness with incident atrial fibrillation: a cohort study. BMC Cardiovasc Disord. 2021 May 20;21(1):247. doi: 10.1186/s12872-021-02057-8. PMID: 34016038; PMCID: PMC8139144.
Copy Download .nbib Format: NLM
Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study.

Journal of the American Heart Association

Wang W, Norby FL, Zhang MJ, Reyes JL, Shah AM, Soliman EZ, Lutsey PL, Alonso A, Solomon SD, Inciardi RM, Chen LY.
PMID: 34713724
J Am Heart Assoc. 2021 Nov 02;10(21):e021723. doi: 10.1161/JAHA.121.021723. Epub 2021 Oct 29.

Background Black Americans have more atrial fibrillation risk factors but lower atrial fibrillation risk than White Americans. Left atrial (LA) enlargement and/or dysfunction, frequent atrial tachycardia (AT), and premature atrial contractions (PAC) are associated with increased atrial fibrillation risk....

Cite
Wang W, Norby FL, Zhang MJ, et al. Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study. J Am Heart Assoc. 2021;10(21):e021723doi: 10.1161/JAHA.121.021723.
Wang, W., Norby, F. L., Zhang, M. J., Reyes, J. L., Shah, A. M., Soliman, E. Z., Lutsey, P. L., Alonso, A., Solomon, S. D., Inciardi, R. M., & Chen, L. Y. (2021). Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study. Journal of the American Heart Association, 10(21), e021723. https://doi.org/10.1161/JAHA.121.021723
Wang, Wendy, et al. "Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study." Journal of the American Heart Association vol. 10,21 (2021): e021723. doi: https://doi.org/10.1161/JAHA.121.021723
Wang W, Norby FL, Zhang MJ, Reyes JL, Shah AM, Soliman EZ, Lutsey PL, Alonso A, Solomon SD, Inciardi RM, Chen LY. Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study. J Am Heart Assoc. 2021 Nov 02;10(21):e021723. doi: 10.1161/JAHA.121.021723. Epub 2021 Oct 29. PMID: 34713724.
Copy Download .nbib Format: NLM
Associations of anger, vital exhaustion, anti-depressant use, and poor social ties with incident atrial fibrillation: The Atherosclerosis Risk in Communities Study.

European journal of preventive cardiology

Garg PK, Claxton JS, Soliman EZ, Chen LY, Lewis TT, Mosley T, Alonso A.
PMID: 34021575
Eur J Prev Cardiol. 2021 May 22;28(6):633-640. doi: 10.1177/2047487319897163.

BACKGROUND: We examined the relationships of anger, vital exhaustion, anti-depressant use, and poor social ties with incident atrial fibrillation in a biracial cohort of middle and older-aged adults.METHODS: This analysis included 11,445 Atherosclerosis Risk in Communities Study participants who...

Cite
Garg PK, Claxton JS, Soliman EZ, et al. Associations of anger, vital exhaustion, anti-depressant use, and poor social ties with incident atrial fibrillation: The Atherosclerosis Risk in Communities Study. Eur J Prev Cardiol. 2021;28(6):633-640doi: 10.1177/2047487319897163.
Garg, P. K., Claxton, J. S., Soliman, E. Z., Chen, L. Y., Lewis, T. T., Mosley, T., & Alonso, A. (2021). Associations of anger, vital exhaustion, anti-depressant use, and poor social ties with incident atrial fibrillation: The Atherosclerosis Risk in Communities Study. European journal of preventive cardiology, 28(6), 633-640. https://doi.org/10.1177/2047487319897163
Garg, Parveen K, et al. "Associations of anger, vital exhaustion, anti-depressant use, and poor social ties with incident atrial fibrillation: The Atherosclerosis Risk in Communities Study." European journal of preventive cardiology vol. 28,6 (2021): 633-640. doi: https://doi.org/10.1177/2047487319897163
Garg PK, Claxton JS, Soliman EZ, Chen LY, Lewis TT, Mosley T, Alonso A. Associations of anger, vital exhaustion, anti-depressant use, and poor social ties with incident atrial fibrillation: The Atherosclerosis Risk in Communities Study. Eur J Prev Cardiol. 2021 May 22;28(6):633-640. doi: 10.1177/2047487319897163. PMID: 34021575.
Copy Download .nbib Format: NLM
Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis.

Research and practice in thrombosis and haemostasis

Zakai NA, Walker RF, MacLehose RF, Koh I, Alonso A, Lutsey PL.
PMID: 34430789
Res Pract Thromb Haemost. 2021 Aug 17;5(6):e12575. doi: 10.1002/rth2.12575. eCollection 2021 Aug.

BACKGROUND: Venous thromboembolism (VTE) affects nearly 1 million Americans annually, and many benefit from continued anticoagulation after the initial 3- to 6-month treatment period (secondary prevention).OBJECTIVES: To determine whether warfarin, apixaban, or rivaroxaban is associated with reduced recurrent VTE...

Cite
Zakai NA, Walker RF, MacLehose RF, et al. Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis. Res Pract Thromb Haemost. 2021;5(6):e12575doi: 10.1002/rth2.12575.
Zakai, N. A., Walker, R. F., MacLehose, R. F., Koh, I., Alonso, A., & Lutsey, P. L. (2021). Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis. Research and practice in thrombosis and haemostasis, 5(6), e12575. https://doi.org/10.1002/rth2.12575
Zakai, Neil A, et al. "Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis." Research and practice in thrombosis and haemostasis vol. 5,6 (2021): e12575. doi: https://doi.org/10.1002/rth2.12575
Zakai NA, Walker RF, MacLehose RF, Koh I, Alonso A, Lutsey PL. Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis. Res Pract Thromb Haemost. 2021 Aug 17;5(6):e12575. doi: 10.1002/rth2.12575. eCollection 2021 Aug. PMID: 34430789; PMCID: PMC8371351.
Copy Download .nbib Format: NLM
Epigenetic Age and the Risk of Incident Atrial Fibrillation.

Circulation

Roberts JD, Vittinghoff E, Lu AT, Alonso A, Wang B, Sitlani CM, Mohammadi-Shemirani P, Fornage M, Kornej J, Brody JA, Arking DE, Lin H, Heckbert SR, Prokic I, Ghanbari M, Skanes AC, Bartz TM, Perez MV, Taylor KD, Lubitz SA, Ellinor PT, Lunetta KL, Pankow JS, Paré G, Sotoodehnia N, Benjamin EJ, Horvath S, Marcus GM.
PMID: 34587750
Circulation. 2021 Dec 14;144(24):1899-1911. doi: 10.1161/CIRCULATIONAHA.121.056456. Epub 2021 Sep 30.

BACKGROUND: The most prominent risk factor for atrial fibrillation (AF) is chronological age; however, underlying mechanisms are unexplained. Algorithms using epigenetic modifications to the human genome effectively predict chronological age. Chronological and epigenetic predicted ages may diverge in a...

Cite
Roberts JD, Vittinghoff E, Lu AT, et al. Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation. 2021;144(24):1899-1911doi: 10.1161/CIRCULATIONAHA.121.056456.
Roberts, J. D., Vittinghoff, E., Lu, A. T., Alonso, A., Wang, B., Sitlani, C. M., Mohammadi-Shemirani, P., Fornage, M., Kornej, J., Brody, J. A., Arking, D. E., Lin, H., Heckbert, S. R., Prokic, I., Ghanbari, M., Skanes, A. C., Bartz, T. M., Perez, M. V., Taylor, K. D., Lubitz, S. A., Ellinor, P. T., Lunetta, K. L., Pankow, J. S., Paré, G., Sotoodehnia, N., Benjamin, E. J., Horvath, S., & Marcus, G. M. (2021). Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation, 144(24), 1899-1911. https://doi.org/10.1161/CIRCULATIONAHA.121.056456
Roberts, Jason D, et al. "Epigenetic Age and the Risk of Incident Atrial Fibrillation." Circulation vol. 144,24 (2021): 1899-1911. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.056456
Roberts JD, Vittinghoff E, Lu AT, Alonso A, Wang B, Sitlani CM, Mohammadi-Shemirani P, Fornage M, Kornej J, Brody JA, Arking DE, Lin H, Heckbert SR, Prokic I, Ghanbari M, Skanes AC, Bartz TM, Perez MV, Taylor KD, Lubitz SA, Ellinor PT, Lunetta KL, Pankow JS, Paré G, Sotoodehnia N, Benjamin EJ, Horvath S, Marcus GM. Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation. 2021 Dec 14;144(24):1899-1911. doi: 10.1161/CIRCULATIONAHA.121.056456. Epub 2021 Sep 30. PMID: 34587750; PMCID: PMC8671333.
Copy Download .nbib Format: NLM
Epigenetic Age and the Risk of Incident Atrial Fibrillation.

Circulation

Roberts JD, Vittinghoff E, Lu AT, Alonso A, Wang B, Sitlani CM, Mohammadi-Shemirani P, Fornage M, Kornej J, Brody JA, Arking DE, Lin H, Heckbert SR, Prokic I, Ghanbari M, Skanes AC, Bartz TM, Perez MV, Taylor KD, Lubitz SA, Ellinor PT, Lunetta KL, Pankow JS, Paré G, Sotoodehnia N, Benjamin EJ, Horvath S, Marcus GM.
PMID: 34587750
Circulation. 2021 Dec 14;144(24):1899-1911. doi: 10.1161/CIRCULATIONAHA.121.056456. Epub 2021 Sep 30.

BACKGROUND: The most prominent risk factor for atrial fibrillation (AF) is chronological age; however, underlying mechanisms are unexplained. Algorithms using epigenetic modifications to the human genome effectively predict chronological age. Chronological and epigenetic predicted ages may diverge in a...

Cite
Roberts JD, Vittinghoff E, Lu AT, et al. Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation. 2021;144(24):1899-1911doi: 10.1161/CIRCULATIONAHA.121.056456.
Roberts, J. D., Vittinghoff, E., Lu, A. T., Alonso, A., Wang, B., Sitlani, C. M., Mohammadi-Shemirani, P., Fornage, M., Kornej, J., Brody, J. A., Arking, D. E., Lin, H., Heckbert, S. R., Prokic, I., Ghanbari, M., Skanes, A. C., Bartz, T. M., Perez, M. V., Taylor, K. D., Lubitz, S. A., Ellinor, P. T., Lunetta, K. L., Pankow, J. S., Paré, G., Sotoodehnia, N., Benjamin, E. J., Horvath, S., & Marcus, G. M. (2021). Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation, 144(24), 1899-1911. https://doi.org/10.1161/CIRCULATIONAHA.121.056456
Roberts, Jason D, et al. "Epigenetic Age and the Risk of Incident Atrial Fibrillation." Circulation vol. 144,24 (2021): 1899-1911. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.056456
Roberts JD, Vittinghoff E, Lu AT, Alonso A, Wang B, Sitlani CM, Mohammadi-Shemirani P, Fornage M, Kornej J, Brody JA, Arking DE, Lin H, Heckbert SR, Prokic I, Ghanbari M, Skanes AC, Bartz TM, Perez MV, Taylor KD, Lubitz SA, Ellinor PT, Lunetta KL, Pankow JS, Paré G, Sotoodehnia N, Benjamin EJ, Horvath S, Marcus GM. Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation. 2021 Dec 14;144(24):1899-1911. doi: 10.1161/CIRCULATIONAHA.121.056456. Epub 2021 Sep 30. PMID: 34587750; PMCID: PMC8671333.
Copy Download .nbib Format: NLM
Epigenetic Age and the Risk of Incident Atrial Fibrillation.

Circulation

Roberts JD, Vittinghoff E, Lu AT, Alonso A, Wang B, Sitlani CM, Mohammadi-Shemirani P, Fornage M, Kornej J, Brody JA, Arking DE, Lin H, Heckbert SR, Prokic I, Ghanbari M, Skanes AC, Bartz TM, Perez MV, Taylor KD, Lubitz SA, Ellinor PT, Lunetta KL, Pankow JS, Paré G, Sotoodehnia N, Benjamin EJ, Horvath S, Marcus GM.
PMID: 34587750
Circulation. 2021 Dec 14;144(24):1899-1911. doi: 10.1161/CIRCULATIONAHA.121.056456. Epub 2021 Sep 30.

BACKGROUND: The most prominent risk factor for atrial fibrillation (AF) is chronological age; however, underlying mechanisms are unexplained. Algorithms using epigenetic modifications to the human genome effectively predict chronological age. Chronological and epigenetic predicted ages may diverge in a...

Cite
Roberts JD, Vittinghoff E, Lu AT, et al. Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation. 2021;144(24):1899-1911doi: 10.1161/CIRCULATIONAHA.121.056456.
Roberts, J. D., Vittinghoff, E., Lu, A. T., Alonso, A., Wang, B., Sitlani, C. M., Mohammadi-Shemirani, P., Fornage, M., Kornej, J., Brody, J. A., Arking, D. E., Lin, H., Heckbert, S. R., Prokic, I., Ghanbari, M., Skanes, A. C., Bartz, T. M., Perez, M. V., Taylor, K. D., Lubitz, S. A., Ellinor, P. T., Lunetta, K. L., Pankow, J. S., Paré, G., Sotoodehnia, N., Benjamin, E. J., Horvath, S., & Marcus, G. M. (2021). Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation, 144(24), 1899-1911. https://doi.org/10.1161/CIRCULATIONAHA.121.056456
Roberts, Jason D, et al. "Epigenetic Age and the Risk of Incident Atrial Fibrillation." Circulation vol. 144,24 (2021): 1899-1911. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.056456
Roberts JD, Vittinghoff E, Lu AT, Alonso A, Wang B, Sitlani CM, Mohammadi-Shemirani P, Fornage M, Kornej J, Brody JA, Arking DE, Lin H, Heckbert SR, Prokic I, Ghanbari M, Skanes AC, Bartz TM, Perez MV, Taylor KD, Lubitz SA, Ellinor PT, Lunetta KL, Pankow JS, Paré G, Sotoodehnia N, Benjamin EJ, Horvath S, Marcus GM. Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation. 2021 Dec 14;144(24):1899-1911. doi: 10.1161/CIRCULATIONAHA.121.056456. Epub 2021 Sep 30. PMID: 34587750; PMCID: PMC8671333.
Copy Download .nbib Format: NLM
Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism.

Journal of the American Heart Association

Alonso A, Norby FL, MacLehose RF, Zakai NA, Walker RF, Adam TJ, Lutsey PL.
PMID: 34514806
J Am Heart Assoc. 2021 Sep 21;10(18):e021227. doi: 10.1161/JAHA.121.021227. Epub 2021 Sep 13.

Background Current scores for bleeding risk assessment in patients with venous thromboembolism (VTE) undergoing oral anticoagulation have limited predictive capacity. We developed and internally validated a bleeding prediction model using healthcare claims data. Methods and Results We selected patients...

Cite
Alonso A, Norby FL, MacLehose RF, et al. Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism. J Am Heart Assoc. 2021;10(18):e021227doi: 10.1161/JAHA.121.021227.
Alonso, A., Norby, F. L., MacLehose, R. F., Zakai, N. A., Walker, R. F., Adam, T. J., & Lutsey, P. L. (2021). Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism. Journal of the American Heart Association, 10(18), e021227. https://doi.org/10.1161/JAHA.121.021227
Alonso, Alvaro, et al. "Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism." Journal of the American Heart Association vol. 10,18 (2021): e021227. doi: https://doi.org/10.1161/JAHA.121.021227
Alonso A, Norby FL, MacLehose RF, Zakai NA, Walker RF, Adam TJ, Lutsey PL. Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism. J Am Heart Assoc. 2021 Sep 21;10(18):e021227. doi: 10.1161/JAHA.121.021227. Epub 2021 Sep 13. PMID: 34514806.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 24 entries